Showing results (111-120 of 131) with videos related to
Sort By:
Pageof 14
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2012
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticariaM Magerl, M Rother, T Bieber, et al.Science (New York, N.Y.)|May 19, 1995
Dust measurements at high ecliptic latitudesM Baguhl, D P Hamilton, E Grün, et al.Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.Allergy|September 24, 2009
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaT Zuberbier, R Asero, C Bindslev-Jensen, et al.Allergy|September 24, 2009
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticariaT Zuberbier, R Asero, C Bindslev-Jensen, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 8, 2018
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]E Haufe, S Abraham, A Heratizadeh, et al.The British Journal of Dermatology|September 21, 2020
The global burden of chronic urticaria for the patient and societyM Gonçalo, A Gimenéz-Arnau, M Al-Ahmad, et al.The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Risk Factors for Household Transmission of Vibrio cholerae in Dhaka, Bangladesh (CHoBI7 Trial)Vanessa Burrowes, Jamie Perin, Shirajum Monira, et al.The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.Journal of Clinical Pharmacology|December 19, 2003
Pharmacokinetics of etoricoxib in patients with renal impairmentNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.Pageof 14